OncoMark Ltd. is a private company centred on the development and application of biomarker panels, particularly supporting oncology drug development. A major focus of the company is to provide the link from -omic level discovery to validation via the use of multiplex antibody-based assays and high-throughput tissue microarray screening. OncoMark also conducts in-house research and development to create unique multi-marker assays for use in the discrimination of patient response to drug therapies and apply novel in-house image analysis toolkit for assessment of IHC-based markers at the subcellular compartmental level. This is of particular benefit to the pharmaceutical and health authority sectors.

TypePrivate
HQBelfield, IE
Founded2007
Size (employees)17 (est)
Websiteoncomark.com
Oncomark was founded in 2007 and is headquartered in Belfield, IE
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Oncomark

Desmond OLeary

Desmond OLeary

CEO
Stephen Penney

Stephen Penney

CFO
William Gallagher

William Gallagher

Chief Scientific Officer
Máirín Rafferty

Máirín Rafferty

Chief Operations Officer
Show more

Oncomark Office Locations

Oncomark has an office in Belfield
Belfield, (HQ)
University College Dublin Stillorgan Rd
Show all (1)
Report incorrect company information

Oncomark Financials and Metrics

Summary Metrics

Founding Date

2007

Oncomark total Funding

$4.9 m

Oncomark latest funding size

$2.22 m

Time since last funding

2 years ago

Oncomark investors

Oncomark's latest funding round in February 2017 was reported to be $2.2 m. In total, Oncomark has raised $4.9 m
View all funding rounds
Report incorrect company information

Oncomark Online and Social Media Presence

Embed Graph
Report incorrect company information

Oncomark Blogs

October 2018: OncoMark attending ESMO

October 2018: OncoMark to attend the European Society of Medical Oncology (ESMO) 2018 Congress Members of the OncoMark team will be attending the European Society of Medical Oncology 2018 Congress in Munich, Germany, from the 19th- 22nd October. Mr. Des O’Leary (CEO), Mr William Gallagher (Chief S…

August 2018 - OncoMasTR test CE marked

  OncoMark Ltd are proud to announce the CE marking of the OncoMasTR test. OncoMark today announced its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of OncoMasTR, a gene expression profiling test for early-stage breast cancer prognosis. The OncoMa…

July 2018 - OncoMark receives ISO 13485:2016 Certification

OncoMark Ltd is pleased to announce that the company’s Quality Management System has been certified to ISO 13485:2016 by leading certification body, BSI. “This significant milestone is a recognition of our commitment to adopting best practice in design, development and manufacturing here in OncoMa…

Oncomark Company Life and Culture

Report incorrect company information

Oncomark Frequently Asked Questions

  • When was Oncomark founded?

    Oncomark was founded in 2007.

  • Who are Oncomark key executives?

    Oncomark's key executives are Desmond OLeary, Stephen Penney and William Gallagher.

  • How many employees does Oncomark have?

    Oncomark has 17 employees.

  • Who are Oncomark competitors?

    Competitors of Oncomark include Kiniksa Pharmaceuticals, Sartorius Stedim BioOutsource and Neurosearch.

  • Where is Oncomark headquarters?

    Oncomark headquarters is located at University College Dublin Stillorgan Rd, Belfield.

  • Where are Oncomark offices?

    Oncomark has an office in Belfield.

  • How many offices does Oncomark have?

    Oncomark has 1 office.